223 related articles for article (PubMed ID: 27497236)
1. Two anti-angiogenic TKI-PET tracers, [(11)C]axitinib and [(11)C]nintedanib: Radiosynthesis, in vivo metabolism and initial biodistribution studies in rodents.
Slobbe P; Poot AJ; Haumann R; Schuit RC; Windhorst AD; van Dongen GA
Nucl Med Biol; 2016 Oct; 43(10):612-24. PubMed ID: 27497236
[TBL] [Abstract][Full Text] [Related]
2. [¹¹C]Sorafenib: radiosynthesis and preclinical evaluation in tumor-bearing mice of a new TKI-PET tracer.
Poot AJ; van der Wildt B; Stigter-van Walsum M; Rongen M; Schuit RC; Hendrikse NH; Eriksson J; van Dongen GA; Windhorst AD
Nucl Med Biol; 2013 May; 40(4):488-97. PubMed ID: 23522977
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, metabolism, and excretion of [14C]axitinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in humans.
Smith BJ; Pithavala Y; Bu HZ; Kang P; Hee B; Deese AJ; Pool WF; Klamerus KJ; Wu EY; Dalvie DK
Drug Metab Dispos; 2014 May; 42(5):918-31. PubMed ID: 24608633
[TBL] [Abstract][Full Text] [Related]
4. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of Axitinib Derivatives.
Wei N; Liang J; Peng S; Sun Q; Dai Q; Dong M
Molecules; 2018 Mar; 23(4):. PubMed ID: 29570686
[TBL] [Abstract][Full Text] [Related]
6. Differential impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on axitinib brain accumulation and oral plasma pharmacokinetics.
Poller B; Iusuf D; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Drug Metab Dispos; 2011 May; 39(5):729-35. PubMed ID: 21282407
[TBL] [Abstract][Full Text] [Related]
7. A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [(11)C]erlotinib and [(18)F]afatinib in lung cancer-bearing mice.
Slobbe P; Windhorst AD; Stigter-van Walsum M; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
EJNMMI Res; 2015; 5():14. PubMed ID: 25853020
[TBL] [Abstract][Full Text] [Related]
8. Radiosynthesis and biological evaluation of N-(2-[
Tang C; Nie D; Tang G; Gao S; Liu S; Wen F; Tang X
Nucl Med Biol; 2017 Jul; 50():39-46. PubMed ID: 28456080
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
[TBL] [Abstract][Full Text] [Related]
10. Development of [11C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts.
Slobbe P; Windhorst AD; Adamzek K; Bolijn M; Schuit RC; Heideman DAM; van Dongen GAMS; Poot AJ
Oncotarget; 2017 Jun; 8(24):38337-38350. PubMed ID: 28418885
[TBL] [Abstract][Full Text] [Related]
11. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and radiopharmacological investigation of 3-[4'-[(18)F]fluorobenzylidene]indolin-2-one as possible tyrosine kinase inhibitor.
Kniess T; Bergmann R; Kuchar M; Steinbach J; Wuest F
Bioorg Med Chem; 2009 Nov; 17(22):7732-42. PubMed ID: 19822433
[TBL] [Abstract][Full Text] [Related]
13. Radiosynthesis, biodistribution and imaging of [11C]YM155, a novel survivin suppressant, in a human prostate tumor-xenograft mouse model.
Murakami Y; Matsuya T; Kita A; Yamanaka K; Noda A; Mitsuoka K; Nakahara T; Miyoshi S; Nishimura S
Nucl Med Biol; 2013 Feb; 40(2):221-6. PubMed ID: 23141550
[TBL] [Abstract][Full Text] [Related]
14. Radiosynthesis of a ¹⁸F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo.
Kniess T; Laube M; Bergmann R; Sehn F; Graf F; Steinbach J; Wuest F; Pietzsch J
Bioorg Med Chem; 2012 Jun; 20(11):3410-21. PubMed ID: 22560838
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of [(11)C]methyl-losartan and [(11)C]methyl-EXP3174 for PET imaging of renal AT1receptor in rats.
Ismail B; Hadizad T; Antoun R; Lortie M; deKemp RA; Beanlands RS; DaSilva JN
Nucl Med Biol; 2015 Nov; 42(11):850-7. PubMed ID: 26300209
[TBL] [Abstract][Full Text] [Related]
16. Radiosynthesis and biological evaluation of
Huang S; Han Y; Chen M; Hu K; Qi Y; Sun P; Wang M; Wu H; Li G; Wang Q; Du Z; Zhang K; Zhao S; Zheng X
Bioorg Med Chem Lett; 2018 Apr; 28(6):1143-1148. PubMed ID: 29486966
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging.
Zha Z; Zhu L; Liu Y; Du F; Gan H; Qiao J; Kung HF
Nucl Med Biol; 2011 May; 38(4):501-8. PubMed ID: 21531287
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of [
Carlucci G; Carney B; Sadique A; Vansteene A; Tang J; Reiner T
Nucl Med Biol; 2017 May; 48():9-15. PubMed ID: 28157626
[TBL] [Abstract][Full Text] [Related]
19. A useful PET probe [
Kawamura K; Shimoda Y; Yui J; Zhang Y; Yamasaki T; Wakizaka H; Hatori A; Xie L; Kumata K; Fujinaga M; Ogawa M; Kurihara Y; Nengaki N; Zhang MR
Nucl Med Biol; 2017 Feb; 45():1-7. PubMed ID: 27835825
[TBL] [Abstract][Full Text] [Related]
20. Does axitinib (AG-01376) have a future role in metastatic renal cell carcinoma and other malignancies?
Goldstein R; Pickering L; Larkin J
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1545-57. PubMed ID: 20942625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
